Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1955 1
1959 1
1961 3
1962 1
1963 1
1964 2
1965 2
1967 2
1969 1
1970 2
1971 2
1972 4
1973 3
1974 2
1975 10
1976 4
1977 1
1978 5
1979 5
1980 6
1981 6
1982 18
1983 12
1984 13
1985 13
1986 14
1987 7
1988 17
1989 13
1990 20
1991 14
1992 15
1993 7
1994 13
1995 12
1996 24
1997 21
1998 21
1999 31
2000 27
2001 21
2002 29
2003 16
2004 26
2005 33
2006 24
2007 28
2008 33
2009 32
2010 36
2011 26
2012 32
2013 34
2014 37
2015 41
2016 51
2017 46
2018 35
2019 45
2020 76
2021 69
2022 45
2023 45
2024 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,161 results

Results by year

Filters applied: . Clear all
Page 1
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: katayama h. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
Development of autoantibody signatures for common cancers.
Kobayashi M, Katayama H, Fahrmann JF, Hanash SM. Kobayashi M, et al. Among authors: katayama h. Semin Immunol. 2020 Feb;47:101388. doi: 10.1016/j.smim.2020.101388. Epub 2020 Jan 8. Semin Immunol. 2020. PMID: 31924500 Review.
Advance care planning in metastatic breast cancer.
Matsuoka J, Kunitomi T, Nishizaki M, Iwamoto T, Katayama H. Matsuoka J, et al. Among authors: katayama h. Chin Clin Oncol. 2018 Jun;7(3):33. doi: 10.21037/cco.2018.06.03. Chin Clin Oncol. 2018. PMID: 30056735 Free article. Review.
A randomized controlled trial comparing laparoscopic surgery with open surgery in palliative resection of primary tumor in incurable Stage IV colorectal cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE trial).
Inomata M, Akagi T, Katayama H, Kimura A, Mizusawa J, Etoh T, Yamaguchi S, Ito M, Kinugasa Y, Saida Y, Hasegawa H, Ota M, Kanemitsu Y, Shimada Y, Kitano S; Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group. Inomata M, et al. Among authors: katayama h. Jpn J Clin Oncol. 2014 Nov;44(11):1123-6. doi: 10.1093/jjco/hyu115. Epub 2014 Aug 25. Jpn J Clin Oncol. 2014. PMID: 25156683 Clinical Trial.
Double scimitar signs.
Miyoshi S, Katayama H, Ito R, Higaki J. Miyoshi S, et al. Among authors: katayama h. Intern Med. 2013;52(14):1657-8. doi: 10.2169/internalmedicine.52.0626. Epub 2013 Jul 15. Intern Med. 2013. PMID: 23857106 Free article. No abstract available.
1,161 results